New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors

被引：22

作者：

Cimetière, B ^{[1
]}

Dubuffet, T ^{[1
]}

Landras, C ^{[1
]}

Descombes, JJ ^{[1
]}

Simonet, S ^{[1
]}

Verbeuren, TJ ^{[1
]}

Lavielle, G ^{[1
]}

机构：

[1] Inst Rech Servier, Ctr Rech, F-78290 Croissy Sur Seine, France

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 11期

关键词：

D O I：

10.1016/S0960-894X(98)00221-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A pyridine group was linked to the tetrahydronaphthalene moiety of the derivatives described in the preceding paper, to afford new combined thromboxane receptor (TP-receptor) antagonists and synthase inhibitors. The most interesting compound Lf inhibits TXA2 synthase with an IC50 value of 0.64 mu M and the aggregation of human platelets with an IC50 value of 0.063 mu M and shows a long duration of action in different species after oral administration. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：1381 / 1386

页数：6

共 50 条

[31] INHIBITORS OF THROMBOXANE SYNTHASE IN HUMAN PLATELETS
DICZFALUSY, U
HAMMARSTROM, S
FEBS LETTERS, 1977, 82 (01) : 107 - 110
[32] INVITRO CHARACTERIZATION OF CGS 22652 - A COMBINED THROMBOXANE RECEPTOR ANTAGONIST (TXRA) THROMBOXANE SYNTHASE INHIBITOR (TXSI)
COHEN, DS
BHAGWAT, S
DOTSON, R
MATHIS, J
FURNESS, P
LOUZAN, M
LEE, W
PEPPARD, J
GUDE, C
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1077 - 1077
[33] THE MODE OF ACTION OF THROMBOXANE SYNTHASE INHIBITORS
ULLRICH, V
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 5 - MEDI
[34] The role of thromboxane synthase, prostacyclin synthase and the thromboxane receptor in the progression of oesophageal and their relationship to survival
Lynch, S.
Cathcart, M. C.
McGarrigle, S.
Reynolds, J. V.
Pidgeon, G.
BRITISH JOURNAL OF SURGERY, 2012, 99 : 36 - 36
[35] THROMBOXANE A2 RECEPTOR ANTAGONISTS
HALL, SE
MEDICINAL RESEARCH REVIEWS, 1991, 11 (05) : 503 - 579
[36] GASTROPROTECTIVE EFFECTS OF THROMBOXANE RECEPTOR ANTAGONISTS
OGLETREE, ML
OKEEFE, EH
DURHAM, SK
RUBIN, B
ABERG, G
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (01): : 374 - 380
[37] THROMBOXANE-A2 RECEPTOR ANTAGONISTS - SYNTHESIS AND ACTIVITIES OF PHENYLSULFONAMIDO DERIVATIVES
MAIS, DE
MOHAMADI, F
DUBE, GP
KURTZ, WL
BRUNE, KA
UTTERBACK, BG
SPEES, MM
JAKUBOWSKI, JA
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (08) : 821 - 827
[38] IMMUNOHISTOCHEMICAL LOCALIZATION OF THROMBOXANE RECEPTOR AND THROMBOXANE SYNTHASE IN RAT-KIDNEY
TAKAHASHI, N
TAKEUCHI, K
ABE, T
TSUTSUMI, E
ABE, K
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 762 - 762
[39] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .1. (+/-)-(3-PYRIDINYLBICYCLOHEPTYL)ALKANOIC ACIDS
BHAGWAT, SS
GUDE, C
COHEN, DS
LEE, W
FURNESS, P
CLARKE, FH
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) : 1790 - 1797
[40] Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: Correlation with plaque composition
Cyrus, Tillmann
Ding, Tao
Pratico, Domenico
ATHEROSCLEROSIS, 2010, 208 (02) : 376 - 381

← 1 2 3 4 5 →